跳至主要内容
临床试验/NCT04358497
NCT04358497Unknown4 期

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

Hospital de Clínicas Dr. Manuel Quintela0 个研究点目标入组 120 人开始时间: 2020年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
120
主要终点
visual analogue scale (VAS)

研究概览

简要总结

Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen medical treatment and only the best chronic medical treatment available diosmin-hisperidine and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion syndrome in public assistance in Montevideo, Uruguay.

详细描述

Pelvic congestion syndrome (PCS) is a recognized and frequent cause of Chronic Pelvic Pain (10% to 30%). It is defined as the presence of chronic symptoms, which may include pelvic pain, perineal heaviness, urinary urgency and postcoital pain, caused by reflux and / or obstruction of the gonadic and / or pelvic veins, and that may be associated with vulvar, perineal and lower limbs varicose veins.

There is no standard approach to managing PCS. According to expert recommendations, therapies should be individualized according to the patient's symptoms and needs.

Medical treatment options include progestagens, danazol, combined oral hormonal contraceptives, phlebotonics such as hisperidine-added diosmin, non-steroidal anti-inflammatory drugs and gonadotropin-releasing hormone (GnRH) agonists

Currently, the only accepted chronic medical treatment is the association of non-steroidal and phlebotonic anti-inflammatories, but they have shown a poor symptomatic benefit in reducing pain.

Surgical treatment has evolved over time mainly in the hands of laparoscopic techniques, currently the endovascular option is the most widely accepted for presenting excellent long-term results with abolition of pain in up to 90% at 2 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Phlebography will be performed to both groups. On the experimental group, the treatment of the pelvic congestion will be performed, while the procedure will be stopped on the control group. Neither the patient or the reference gynecologist will be informed if the treatment took place.

入排标准

性别
Female
接受健康志愿者

入选标准

  • Active gynecological age
  • Chronic pelvic pain diagnosed by gynecologist of at least 6 months of evolution.
  • Transvaginal duplex ultrasound: presence of periuterine varicose veins defined by veins larger than 5mm in diameter with reflux greater than 0.5 seconds on Valsava maneuvers.

排除标准

  • Presence of other causes of chronic pelvic pain: endometriosis, pelvic inflammatory disease, postoperative adhesions, uterine myoma, adenomyosis, ovarian tumors, polycystic ovary.
  • Fibromyalgia
  • BMI greater than 35
  • Chronic kidney disease
  • thrombophilia
  • Alterationof coagulation.
  • Allergy to iodinated contrast medium.

研究组 & 干预措施

Interventional treatment plus best chronic medical treatment

Experimental

Sandwich embolization ( 2% polidocanol + Coils) Diosmin hisperidin 1g twice a day for 6 months Ibuprofen 500mg 3 times a day for 6 months

干预措施: Medtronic® Concerto® detachable coil system (Device)

Interventional treatment plus best chronic medical treatment

Experimental

Sandwich embolization ( 2% polidocanol + Coils) Diosmin hisperidin 1g twice a day for 6 months Ibuprofen 500mg 3 times a day for 6 months

干预措施: sclerosis (Procedure)

Interventional treatment plus best chronic medical treatment

Experimental

Sandwich embolization ( 2% polidocanol + Coils) Diosmin hisperidin 1g twice a day for 6 months Ibuprofen 500mg 3 times a day for 6 months

干预措施: Diosmin / Hesperidin (Drug)

Interventional treatment plus best chronic medical treatment

Experimental

Sandwich embolization ( 2% polidocanol + Coils) Diosmin hisperidin 1g twice a day for 6 months Ibuprofen 500mg 3 times a day for 6 months

干预措施: Ibuprofen 400 mg (Drug)

Best chronic medical treatment alone

Active Comparator

Diosmin hisperidin 1g twice a day for 6 months Ibuprofen 500mg 3 times a day for 6 months

干预措施: Diosmin / Hesperidin (Drug)

Best chronic medical treatment alone

Active Comparator

Diosmin hisperidin 1g twice a day for 6 months Ibuprofen 500mg 3 times a day for 6 months

干预措施: Ibuprofen 400 mg (Drug)

结局指标

主要结局

visual analogue scale (VAS)

时间窗: 3 months

Pain assessment 1-10 from no pain to severe

Lattinen index

时间窗: 3 months

chronic pain assessment 2-22 from low to high

McGill Pain Questionnaire

时间窗: 3 months

subjective pain experience assessment

次要结局

  • Female sexual function index(3 months)
  • varicose and reflux persistance by transabdominal duplex scan(3 months)
  • varicose and reflux persistance by transvaginal duplex scan(3 months)
  • varicose persistance assesment by tomography(3 months)

研究者

发起方
Hospital de Clínicas Dr. Manuel Quintela
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eduardo Sebastian Sarutte Rosello, MD VS MSc

Vascular Surgery Asistant Professor

Hospital de Clínicas Dr. Manuel Quintela

相似试验